109147 ⎘
Structure or type of the nucleic acid; Type of nucleic acid Nucleic acids forming more than 2 strands, e.g. TFOs
Sub-classes:COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#2Allosteric Conditional Guide RNAs for Cell-Selective Regulation of CRISPR/Cas
#3SIGNAL ACTIVATABLE NUCLEIC ACID CONSTRUCTS WITH WOBBLE BASE PAIRINGS
#4TRIPLE-STRANDED NUCLEIC ACID COMPRISING TFO, KITS AND METHODS FOR DETECTING TARGET SEQUENCE BY USING TFO
#5CRISPR-BASED PROTEIN BARCODING AND SURFACE ASSEMBLY
#6CHIMERIC DOUBLE-STRANDED NUCLEIC ACID
#7Allosteric Conditional Guide RNAs for Cell-Selective Regulation of CRISPR/Cas
#8METHODS AND COMPOSITIONS RELATING TO ENGINEERED GUIDE SYSTEMS FOR ADENOSINE DEAMINASE ACTING ON RNA EDITING
#9METHOD FOR TREATING CARDIOVASCULAR DISEASE
#10TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY
#11HYDROXYMETHYL-MODIFIED GAMMA-PNA COMPOSITIONS AND METHODS OF USE THEREOF
#12Allosteric conditional guide RNAs for cell-selective regulation of CRISPR/Cas
#13COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASE
#14PEPTIDE NUCLEIC ACID COMPOSITIONS WITH MODIFIED HOOGSTEEN BINDING SEGMENTS AND METHODS OF USE THEREOF
#15Antisense oligonucleotides for the treatment of Leber congenital amaurosis
#16CHIMERIC DOUBLE-STRANDED NUCLEIC ACID
#17CIRCULARIZED ENGINEERED RNA AND METHODS
#18METHOD FOR TREATING CARDIOVASCULAR DISEASE
#19COMPOSITIONS AND METHODS FOR NEXT GENERATION SEQUENCING
#20COMPOSITIONS AND METHODS FOR NEXT GENERATION SEQUENCING
#21CRISPR fluorescent guide RNA (fgRNA) to understanding gRNAs expressed from pol II promotors
#22COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS
#23Antisense oligonucleotides for the treatment of leber congenital amaurosis
#24Targeting gene amplification in cancer using triplex formation as a therapeutic strategy
#25COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#26POLYMER-BASED NANOPARTICLES, RELATED FORMULATIONS METHODS, AND APPARATUS
#27Chimeric double-stranded nucleic acid
#28Antisense oligonucleotides for the treatment of Leber congenital amaurosis
#29Chimeric double-stranded nucleic acid
#30Antisense oligonucleotides for the treatment of leber congenital amaurosis
#31COMPLEMENT COMPONENT C5 iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#32Production of stable non-polyadenylated RNAs
#33Chimeric double-stranded nucleic acid
#34Compositions and methods to promote erythropoiesis
#35ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS
#36Methods for modulating ATRX-dependent gene repression
#37Compositions for enhancing targeted gene editing and methods of use thereof
#38Compositions and methods to promote erythropoiesis
#39Methods for inducing glucose uptake
#40NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
#41Production of stable non-polyadenylated RNAs
#42NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF
#43Compositions and methods to promote erythropoiesis
#44Antisense oligonucleotides for the treatment of Leber congenital amaurosis
#45Chimeric double-stranded nucleic acid
#46OSTEOARTHRITIS BIOMARKERS AND USES THEREOF
#47Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
#48TOPICAL THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES COMPRISING COMPOUND CAPABLE OF BINDING SPECIFICALLY TO DNA SEQUENCE
#49Human telomerase catalytic subunit
#50COMPOSITIONS AND METHODS FOR TARGETED INACTIVATION OF HIV CELL SURFACE RECEPTORS
#51Chimeric Molecules to Modulate Gene Expression
#52INTERCALATING TRIPLEXES AND DUPLEXES USING ARYL NAPHTHOIMIDAZOL AND PROCESS FOR THE PREPARATION THEREOF
#53IL-17 Homologous Polypeptides and Therapeutic Uses Thereof
#54SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF
#55Nicked or gapped nucleic acid molecules and uses thereof
#56COMPOSITIONS AND METHODS FOR TARGETED INACTIVATION OF HIV CELL SURFACE RECEPTORS
#57Methods and Compositions for Treating Cancer
#58Osteoarthritis biomarkers and uses thereof
#59Novel tyrosinase-specific anti-gene oligonucleotides as depigmenting agents
#60HYBRIDIZATION-STABILIZING CONSTRUCT
#61Kit for detection of telomerase reverse transcriptase nucleic acids
#62ALLELE SUPPRESSION
#63Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (TINA) and process for the preparation of TINA
#64SUPPRESSION OF POLYMORPHIC ALLELES
#65Methods for regulation of p53 translation and function
#66IL-17 homologous polypeptides and therapeutic uses thereof
#67IL-17 homologous polypeptides and therapeutic uses thereof
#68Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues
#69IL-17 homologous polypeptides and therapeutic uses thereof
#70Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
#71Treatment of HSV-related pathologies using plasmids that make ssDNA
#72Method for eliciting an immune response to human telomerase reverse transcriptase
#73Compounds and Their Use for Specific and Simultaneous Inhibition of Genes Involved In Diseases and Related Drugs
#74Materials and Methods Relating to Cell Cycle Control
#75Regulatory segments of the human gene for telomerase reverse transcriptase
#76Control of apoptosis
#77Genetic suppression and replacement
#78Use of mob-5 in pain
#79Antibody to telomerase reverse transcriptive
#80System for regulating in vivo the expression of a transgene by conditional inhibition
#81Osteoarthritis biomarkers and uses thereof
#82Chemically modified double stranded nucleic acid molecules
#83Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
#84Sp1 and Sp3 targeted cancer therapies and therapeutics
#85Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase
#86Chimeric molecules to modulate gene expression
#87Higher order structure and binding of peptide nucleic acids
#88Vaccine containing the catalytic subunit of telomerase for treating cancer
#89Gene-targeted apoptosis